Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

GSK3A Y279-p
IKKE S21-p
PKACA S21-p
PKCA S21-p
PKCB S21-p
PKCH S21-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Akt1 S21-p
PKACA S21-p
PKCA S21-p
PKCB iso2 S21-p
PKCD S21-p
PKCG S21-p
PKCH S21-p
RSK2 S21-p
Putative upstream phosphatases:
ALPI S21-p
Regulatory protein:
Akt1 S21-p
Akt2 S21-p
Akt3 S21-p
AR S21-p
BRAF S21-p
CYR61 S21-p
E4 S21-p
GRP78 S21-p
GSK3A S21-p
IEX-1 S21-p
IKKE S21-p
ILKAP S21-p
ILK S21-p
IRAK4 S21-p
NRas S21-p
OSBPL8 S21-p
p16-INK4A S21-p
PHLPP2 S21-p
PHLPP S21-p
PPP1R2 S21-p
PPP2CA S278-p
PRP4 Y279-p
PTEN S21-p
RPS23 S21-p
Treatment:
(E)-4-(3-(2-(5-nitroquinolin-2-yl)vinyl)quinolin-2-yl)morpholine S21-p
2-(pyridin-4-yl)-4-(p-tolyl)quinoline S21-p
2-deoxyglucose S21-p
705701 Y279-p
708244 Y279-p
709125 Y279-p
Akt-I-1 S21-p
Akt_inhibitor_IV S21-p
amino_acids S21-p
angiotensin_2 S21-p
anisomycin Y279-p
antibody S21-p , Y279-p
antimycin_A S21-p
B7 S21-p
BAPTA-AM S21-p
cAMP_analog S21-p
celecoxib S21-p
cisplatin S21-p
colforsin S21-p
collagen S21-p
conditioned medium S21-p
convulxin S21-p
CXCL12 Y279-p
cycloheximide Y279-p
depolarization S21-p
EGF S21-p
enzalutamide S21-p
enzastaurin S21-p , Y279-p
Epo S21-p
exercise S21-p
fibronectin S21-p
fMLP S21-p
gefitinib T19-p , S21-p
geldanamycin S21-p
genistein Y279-p
GF109203X S21-p
glucose S21-p
Go_6976 S21-p
Go_6983 S21-p
H-7 S21-p
H-89 S21-p
H2O2 S21-p
HA-1004 S21-p
HB-EGF S21-p
HGF S21-p
hypoxia S21-p
idebenone S21-p
IGF-1 S21-p
IL-1a S21-p
IL-3 S278-p
IL-6 S21-p
imatinib T19-p , S21-p
indirubin Y279-p
insulin S21-p
IP(6) S21-p
isoproterenol S21-p
kenpaullone S21-p , Y279-p
KN-62 S21-p
KP-372-1 S21-p
linoleic_acid S21-p
lithium S21-p , Y279-p
low_K(+) S21-p
LPA S21-p
LPS S21-p
LY2064827 S21-p , Y279-p
LY294002 S21-p
MEK_inhibitor_I S52-p , S63-p
MG132 K360-ub
MG132_withdrawal S41-p , S97-p
ML-9 S21-p
NMDA Y279-p
oleic_acid S21-p
PD98059 S21-p
PKI-402 S21-p
poly-L-lysine S21-p
PP2 Y279-p
purvalanol Y279-p
rapamycin S21-p
retinoic_acid S21-p , Y279-p
Ro31-8220 S21-p
rottlerin S21-p
RRD-251 S21-p , Y279-p
SB203580 S21-p
SB415286 S21-p
SCF S21-p
Sem3A S21-p
serum S21-p , S278-p
serum_withdrawal S21-p
SII_angiotensin_2 S21-p , Y279-p
siRNA S21-p
SN-50 S21-p
sphingosine_1-phosphate S21-p
staurosporine S21-p , Y279-p
Su11274 T19-p , S21-p
thapsigargin S21-p
thrombin S21-p
TNF S21-p
TRAIL S21-p
transplatin S21-p
tunicamycin S21-p
U0126 Y279-p , S282-p
U71322 S21-p
UCN-01 S21-p
vanadate S21-p
wortmannin T19-p , S21-p